Inventor · disambiguated record
Rajendra K. Pandey
Also filed as: PANDEY RAJENDRA · PANDEY RAJENDRA K
14 granted patents·14 pending applications·86 citations·filing 2002–2024
90Inventor score
Files withALIGOS THERAPEUTICS INC13MANOHARAN MUTHIAH5ALNYLAM PHARMACEUTICALS INC3JANSSEN BIOPHARMA INC3IDERA PHARMACEUTICALS INC1
Top patents by PatentIndex Score
28 records- 0195US11549110B2Modified short interfering nucleic acid (siNA) molecules and uses thereofALIGOS THERAPEUTICS INC·Filed 2022·Granted Jan 10, 2023·5 cites·30 claims
- 0292US12129469B2Modified short interfering nucleic acid (siNA) molecules and uses thereofALIGOS THERAPEUTICS INC·Filed 2023·Granted Oct 29, 2024·1 cites·30 claims
- 0392US8962580B2Chemical modifications of monomers and oligonucleotides with cycloadditionMANOHARAN MUTHIAH·Filed 2009·Granted Feb 24, 2015·26 cites·11 claims
- 0492US8008267B2Stabilized immunomodulatory oligonucleotidesIDERA PHARMACEUTICALS INC·Filed 2004·Granted Aug 30, 2011·29 cites·16 claims
- 0589US8431693B2Process for desilylation of oligonucleotidesMANOHARAN MUTHIAH·Filed 2011·Granted Apr 30, 2013·15 cites·28 claims
- 0686US8946175B1Stabilized immunomodulatory oligonucleotidesKANDIMALLA EKAMBAR R·Filed 2011·Granted Feb 3, 2015·5 cites·25 claims
- 0785US11166976B2S-antigen transport inhibiting oligonucleotide polymers and methodsALIGOS THERAPEUTICS INC·Filed 2020·Granted Nov 9, 2021·1 cites·6 claims
- 0884US10793859B2Modified oligonucleotides and methods of useJANSSEN BIOPHARMA INC·Filed 2017·Granted Oct 6, 2020·2 cites·10 claims
- 0983US12077757B2Modified oligonucleotides and methods of useJANSSEN BIOPHARMA INC·Filed 2020·Granted Sep 3, 2024·1 cites·15 claims
- 1081US11466274B2Modified gapmer oligonucleotides and methods of useALIGOS THERAPEUTICS INC·Filed 2020·Granted Oct 11, 2022·1 cites·16 claims
- 1181US2025092400A1Modified Oligonucleotides and Methods of UseJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 1278US2023332153A1Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses ThereofALIGOS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1376US12454691B2Modified short interfering nucleic acid (siNA) molecules and uses thereofALIGOS THERAPEUTICS INC·Filed 2022·Granted Oct 28, 2025·0 cites·29 claims
- 1470US2022364096A1Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses ThereofALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1567US8063198B2Processes and reagents for desilylation of oligonucleotidesMANOHARAN MUTHIAH·Filed 2008·Granted Nov 22, 2011·0 cites·39 claims
- 1666US2022125825A1S-antigen transport inhibiting oligonucleotide polymers and methodsALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1761US8058448B2Processes and reagents for sulfurization of oligonucleotidesMANOHARAN MUTHIAH·Filed 2009·Granted Nov 15, 2011·0 cites·18 claims
- 1859US2022160748A1Conjugates of s-antigen transport inhibiting oligonucleotide polymers having enhanced liver targetingALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1959US2011250138A1Single-stranded and double-stranded oligonucleotides comprising a metal-chelating ligandALNYLAM PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2058US2015203847A1Chemical modifications of monomers and oligonucleotides with cycloadditionALNYLAM PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2157US2005267300A1Processes and reagents for oligonucleotide synthesis and purificationMANOHARAN MUTHIAH·Filed 2005·Application pending·0 cites
- 2256US2019048344A1Chemical modifications of monomers and oligonucleotides with cycloadditionALNYLAM PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2355US2021189392A1S-antigen transport inhibiting oligonucleotide polymers and methodsALIGOS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2455US2021317457A1Antisense oligonucleotide (aso) molecules and uses thereof for coronavirus diseasesALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2555US2022380770A1SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES AND USES THEREOF FOR CORONAVIRUS DISEASESALIGOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2649US12503698B2GalNAc derivativesJANSSEN BIOPHARMA INC·Filed 2018·Granted Dec 23, 2025·0 cites·10 claims
- 2749US2020147124A1S-antigen transport inhibiting oligonucleotide polymers and methodsALIGOS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2840US2003143331A1Attachment of thiophosphate tethered oligonucleotides to a solid surfaceMICROLOGIX BIOTECH INC·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rajendra K. Pandey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →